Author

Ali M Alhomaidan

Observed names: Ali Alhomaidan, Ali M. Alhomaidan
Observed institution: Saudi Food and Drug Authority
ORCID: 0009-0007-4458-1483
Observed ORCID: 0009-0007-4458-1483
OpenAlex ID: A5045974290
2025 · Abdulrahman A. Alsuhibani, Norah A. Alobaid, et al. · Antibiotics · 7
2024 · Malak Almutairi, Aljoharah Algabbani, et al. · Therapeutic Innovation & Regulatory Science · 6
2016 · Ali M Alhomaidan, Ibrahim A Aljuffali, et al. · Generics and Biosimilars Initiative Journal · 6
2024 · Ali M. Alhomaidan, Nawaf G. Al-Murikhi, et al. · Therapeutic Innovation & Regulatory Science · 4
2024 · Turki A. Althunian, Bader R. Alzenaidy, et al. · BMC Medical Research Methodology · 2
2023 · Ali M Alhomaidan, Mohammed Abdulaziz Alageel, et al. · Generics and Biosimilars Initiative Journal · 1
2018 · Gianluca Trifirò, Meteb Al-Foheidi, et al. · Generics and Biosimilars Initiative Journal · 1
2018 · Hajaj M Alhomaidan, Ali M Alhomaidan · Generics and Biosimilars Initiative Journal · 1
2026 · Fuad Fadhel Alotaibi, Abdulrahman A. Alsuhibani, et al. · Expert Review of Pharmacoeconomics & Outcomes Research
2022 · Hamad M. Alhomaidan, Nehal M. Alhomaidan, et al. · Journal of Advances in Medical and Pharmaceutical Sciences
Works count: 11
Citation count: 28
H-index: 4
I10-index:
Year
Topic
Type